human neural stem cells expressing IGF-1 (NSI-532.IGF) / Palisade Bio - LARVOL DELTA

Neuralstem announces issuance of new patent covering broad therapeutic use of neural stem cells (Neuralstem Press Release) - "Neuralstem, Inc....today announced the expansion of their intellectual property portfolio with the recent issuance of a newly published patent. U.S. Patent No. 10,286,010, entitled 'Methods of Treating Neurodegenerative Conditions' was issued on May 14, 2019, by the United States Patent and Trademark Office (USPTO). The patent covers the use of transplanted human neural stem cells for the treatment of neurodegeneration resulting from disease and injury....'It provides Neuralstem with broad protection for...treatment of diseases such as stroke, traumatic brain injury, spinal cord injury, and ALS...'"

Patent